|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This site is dedicated to Cindi McCain & Lou Grubb: Friends & Stroke Survivors....(ALLOW 1 MINUTE TO LOAD)....We search 100's of internet sites for daily news: New York Times, Washington Post, LA Times, Chicago Tribune, Harvard, Yale, UCLA, CNN, FOX, CBS, NBC, ABC, BBC, Journal of American Medical Assoc., New England Journal of Medicine, Mayo Clinic, Johns Hopkins Medicine, Cleveland Clinic, Memorial Sloan- Kettering, Reuters & 100's more...(WE DO NOT ACCEPT ADVERTISING) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Thursday
Pfizer's Lipitor OKd for expanded uses: CLICK HERE FOR MORE
From Reuters March 8, 2007 The Food and Drug Administration has approved expanded use of Pfizer Inc.'s blockbuster cholesterol-lowering medicine Lipitor by five new categories, including one to reduce the risk of non-fatal heart attacks and strokes, the company said Wednesday. The expanded label for the world's top-selling prescription drug will also include its approval for use in reducing the risks of certain types of heart surgery, hospitalization for heart failure and chest pain in patients with heart disease. Pfizer said Lipitor was the first cholesterol-lowering drug to win approval for reducing risk of hospitalization for heart failure. The expanded label may provide Pfizer sales representatives with new ammunition in the battle to stem market erosion as health plans turn up the pressure to switch patients to much less expensive generic versions of Merck & Co.'s Zocor.... |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||